
The new agreement lets Hims & Hers patients obtain FDA-approved tirzepatide and orforglipron at Lilly’s self-pay prices.
Susan Cornell, PharmD, CDE, FAPhA, FAADE discusses the patient counseling points pharmacists should be aware of for antidiabetic agents.
Susan Cornell, PharmD, CDE, FAPhA, FAADE discusses the patient counseling points pharmacists should be aware of for antidiabetic agents.
This video was recorded at APhA's 2016 Annual Meeting and Exposition in Baltimore, Maryland.






